Valeant, Salix agree to cash deal of $173 a share
Valeant Pharmaceuticals agreed to buy Salix Pharmaceuticals for $173 per share Monday morning.
Ce blog propose une analyse des marchés financiers ainsi qu'un portefeuille basé sur une stratégie développée depuis 7 ans.
Valeant Pharmaceuticals agreed to buy Salix Pharmaceuticals for $173 per share Monday morning.
China's trust firms are shifting more cash into frothy capital markets and over-the-counter (OTC) instruments instead of loans.
Shadow banking has come back to life after getting hammered during the crisis; one segment has been especially rampant.
Morgan Stanley's chief U.S. economist explains why she thinks the Fed will wait until 2016 to raise interest rates.